Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd reached its maximum allowed daily gain of 5.0% within the 5% price band, closing at Rs 1005.2. This upper circuit event means that while there was strong buying interest, sellers were absent at prices below the circuit ceiling, resulting in unfilled demand. The total traded volume was 0.2711 lakh shares, with a turnover of Rs 2.71 crore. The narrow intraday range from Rs 969.0 to Rs 1005.2 reflects the price lock mechanism, which restricts further upward movement despite persistent buying pressure. Venus Remedies Ltd’s circuit lock effectively froze trading at the ceiling price, highlighting the imbalance between supply and demand on this session — what does the full demand picture look like for Venus Remedies once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Delivery volumes provide the clearest insight into the quality of the buying on a circuit day. On 18 May 2026, the delivery volume surged to 63,570 shares, marking a remarkable 224.63% increase against the 5-day average delivery volume. This sharp rise in delivery indicates that buyers were not merely speculating intraday but were taking actual ownership of shares, signalling genuine conviction behind the move. Although the total traded volume on the circuit day was mechanically suppressed due to the price lock, the rising delivery component suggests that the rally was supported by long-term buying rather than fleeting momentum. is Venus Remedies' 5% surge backed by improving fundamentals or is this a liquidity-driven micro-cap move? — the delivery data is the most revealing metric on a circuit day.

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a strong bullish trend that preceded the circuit event. The upper circuit gain of 5.0% further amplified this momentum, reinforcing the breakout narrative. The stock’s consistent gains over the last two days, amounting to a 10.24% return, underscore the sustained buying interest. The technical setup suggests that the circuit was not an isolated spike but a continuation of an established upward trend.

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately Rs 1,333 crore, Venus Remedies Ltd is classified as a micro-cap stock. This segment typically experiences thinner liquidity and more pronounced price swings, making upper circuit hits more frequent and impactful. The stock’s liquidity profile shows it is liquid enough for a trade size of Rs 0.09 crore, based on 2% of the 5-day average traded value. While this level of liquidity is reasonable for a micro-cap, it also implies that entering or exiting large positions could be challenging without moving the price significantly. The upper circuit event thus carries a liquidity risk alongside the momentum signal — but with near-zero liquidity and a Rs 1,333 crore market cap, should you be chasing Venus Remedies?

Intraday Price Action

The intraday range on 19 May 2026 was relatively narrow, with the stock moving between Rs 969.0 and Rs 1005.2. The upper circuit price of Rs 1005.2 capped the session’s high, reflecting the maximum permitted gain within the 5% price band. This limited range is typical for circuit-bound stocks, where the price ceiling restricts further upside despite persistent demand. The stock’s ability to maintain the upper circuit price throughout the session indicates strong buyer resolve and a lack of willing sellers at lower levels.

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, an industry known for its growth potential and sensitivity to regulatory and innovation cycles. While the micro-cap status suggests a smaller scale compared to industry giants, the company’s recent price action and delivery volumes hint at growing investor attention. The sector’s overall performance on the day was modest, with the sector gaining 0.77% and the Sensex rising 0.41%, making Venus Remedies Ltd’s 5.0% gain a notable outperformance.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1005.2 capped a 5.0% gain for Venus Remedies Ltd, reflecting strong buying interest that exceeded the supply available at lower prices. The surge in delivery volumes by over 220% against the recent average is a compelling sign of conviction, indicating that buyers are taking long-term positions rather than engaging in speculative intraday trades. The stock’s position above all major moving averages further confirms the bullish trend underpinning this move.

However, as a micro-cap with limited liquidity, the stock carries inherent risks related to thin order books and difficulty in executing large trades without impacting price. The total traded volume on the circuit day was modest, a mechanical consequence of the price lock, but the liquidity profile suggests caution for investors considering sizeable positions. The circuit locked in gains but also locked out buyers who arrived late — after a 5.0% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →